CRSP Competitors & Alternatives

Compare Crispr Therapeutics AG with similar stocks in the same industry

Biotechnology

CRSP

Main Stock
$40.61
-3.86%
Tradestie Score
49
Market Cap
$6.02B
Revenue Growth
13.3%
Analyst Upside
+110.3%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 4/10 Genomics Precision Med Gene Editing
Competitive Moat: None
Core Technology Stack: CRISPR/Cas9 gene editing, ex vivo cell therapy, in vivo delivery
Major Customers 4
Vertex Pharmaceuticals genetic disease patients oncology centers research institutions
Critical Suppliers 4
Thermo Fisher Scientific Illumina contract manufacturing organizations CRISPR component vendors
Direct Ecosystem Rivals 4

Top Competitors

218 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ACLX Arcellx, Inc. Common Stock
$115.07
+0.03%
$4.55B - 50 Compare
PTGX Protagonist Therapeutics, Inc
$125.40
-4.24%
$3.98B 28.1 42 Compare
CRNX Crinetics Pharmaceuticals, Inc.
$84.95
+0.13%
$3.92B - 46 Compare
KYMR Kymera Therapeutics, Inc. Common Stock
$124.79
-2.18%
$3.91B - 47 Compare
ZLAB Zai Lab Limited American Depositary Shares
$23.74
-3.50%
$3.83B - 44 Compare
AAPG Ascentage Pharma Group International American Depository Shares
$13.43
-8.14%
$3.68B - 51 Compare
MIRM Mirum Pharmaceuticals, Inc. Common Stock
$92.92
-1.14%
$3.67B - 38 Compare
ADMA ADMA Biologics, Inc.
$13.70
+0.11%
$3.59B 17.2 28 Compare
ACAD Acadia Pharmaceuticals Inc.
$19.07
+1.71%
$3.58B 8.6 47 Compare
LGND Ligand Pharmaceuticals Inc.
$304.93
-1.25%
$3.49B 127.0 45 Compare

Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2836)

218 stocks in this industry